Best Pharmaceuticals Newsletters in 2026
NewsletterFIT tracks 6 newsletters that cover Pharmaceuticals as a primary topic, all with posts in the last 90 days. By publicly shown subscriber count, the largest are Santa Cruz Works (8K), The Baobab (3K) and GLP-1 Digest (2K).
Updated Nov 5, 2026 · sorted by publicly shown subscribers · methodology
- 1Santa Cruz Works8K subscribers
SubstackEvery two weeks · last post 14 days ago
Santa Cruz Works connects businesses and entrepreneurs with local tech resources, community, and opportunities.
Likely audience: Biotech researchers
- 2The Baobab3K subscribers
SubstackSeveral times a week · last post today
A fresh take on Africa for readers in 131 countries. Three standout stories, three times a week — free and ad-free.
Likely audience: Film enthusiasts
- 3GLP-1 Digest 2K subscribers
SubstackMonthly or less · last post 27 days ago
From recent posts: GLP-1 Digest publishes weekly interviews and analysis covering the GLP-1 market, companion apps, genetic testing, and regulatory issues for investors, healthcare professionals, and entrepreneurs. The publication mixes…
Likely audience: Healthcare investors
- 4
SubstackWeekly · last post 11 days ago
Strategy, capital, and innovation in animal protein
Likely audience: nutrition researchers
- 5
LinkedInWeekly · last post 16 days ago
Weekly straight talk from Doug Drysdale on biopharma execution and lessons learned the hard way
Likely audience: Pharmaceutical executives
- 6
LinkedInEvery two weeks · last post 16 days ago
Investment Analysis of publicly traded companies in Latin America. Join our community of investors interested in LATAM!
Likely audience: Investment analysts
Latest posts from these newsletters
- 🔅 AI’s…The Baobab
- 🔅 The…The Baobab
- 🔅 Turning…The Baobab
- 🔅 Dakar…The Baobab
- 🔅 Hamilton…The Baobab
- Side Effects…Prime Future
- Why the…Santa Cruz Works
- 🔅 How…The Baobab
